Soleno Therapeutics (SLNO) Enterprise Value (2013 - 2026)
Soleno Therapeutics (SLNO) reported Enterprise Value of -$255.6 million for Q1 2026, up 11.84% year-over-year from -$228.5 million in Q1 2025, and up 16.33% quarter-over-quarter from -$305.5 million in Q4 2025.
Soleno Therapeutics (SLNO) Enterprise Value (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 14 years of Enterprise Value data on file, last reported at -$255.6 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$255.6 million, up 11.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$255.6 million (up 11.84% YoY), and the FY2025 annual result was -$305.5 million, down 4.82% from the prior year.
- Enterprise Value advanced to -$255.6 million in Q1 2026 per SLNO's latest filing, from -$305.5 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$7.9 million in Q1 2023 and troughed at -$498.9 million in Q3 2025.
- A 5-year average of -$172.8 million and a median of -$169.7 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value soared 72.76% in 2023, then slumped 1793.67% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$14.6 million in 2022, then slumped by 1062.04% to -$169.7 million in 2023, then plunged by 71.76% to -$291.4 million in 2024, then slipped by 4.82% to -$305.5 million in 2025, then rose by 16.33% to -$255.6 million in 2026.
- Business Quant data shows SLNO's Enterprise Value at -$255.6 million in Q1 2026, -$305.5 million in Q4 2025, and -$498.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | -255.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -255.60 Mn |
| Dec 31, 2025 | -305.47 Mn |
| Sep 30, 2025 | -498.93 Mn |
| Jun 30, 2025 | -286.84 Mn |
| Mar 31, 2025 | -289.93 Mn |
| Dec 31, 2024 | -291.44 Mn |
| Sep 30, 2024 | -256.76 Mn |
| Jun 30, 2024 | -266.12 Mn |
| Mar 31, 2024 | -149.60 Mn |
| Dec 31, 2023 | -169.68 Mn |
| Sep 30, 2023 | -52.40 Mn |
| Jun 30, 2023 | -19.37 Mn |
| Mar 31, 2023 | -7.90 Mn |
| Dec 31, 2022 | -14.60 Mn |
| Sep 30, 2022 | -19.75 Mn |
| Jun 30, 2022 | -24.07 Mn |
| Mar 31, 2022 | -29.00 Mn |
| Dec 31, 2021 | -21.30 Mn |
| Sep 30, 2021 | -28.19 Mn |
| Jun 30, 2021 | -33.60 Mn |